ABSTRACT RNA-binding proteins regulate every aspect of RNA metabolism, including pre-mRNA splicing, mRNA trafficking, stability, and translation. This review summarizes the available information on molecular mechanisms of translational repression by RNAbinding proteins. By using a specific set of well-defined examples, we also describe how regulation can be reversed.
INTRODUCTION
Translational regulation plays an important role in numerous biological situations. In conditions of amino acid starvation, apoptosis, or viral infection, a global response modifies the translational efficiency of most mRNAs in the cell. In other circumstances (e.g., embryonic pattern formation, sex determination, neuronal plasticity) the translation of specific mRNAs is regulated, leaving most cellular transcripts unaffected. Misregulation of global or mRNAspecific translation contributes to disease (Mamane et al. 2006; Kozma et al. 2007; Wiemer 2007) . For example, Fragile X syndrome results from mutations in FMRP, a protein involved in translational regulation at synapses (Zalfa et al. 2006) . While global regulation is normally driven by phosphorylation or proteolysis of key general translation initiation factors, mRNA-specific regulation is exerted by proteins (or microRNAs) that recognize sequence elements usually located in the untranslated regions (UTRs) of the transcript. Most often, regulation involves repression by proteins that bind to the 39 UTR. Translational repression can be reversed, and this is generally achieved by removal of the repressor from its binding site on the mRNA or by remodeling of the repressor complex. In this review we briefly summarize the current knowledge on mechanisms of translational repression by RNA-binding proteins, as well as how regulation can be reversed. More extensive reviews concerning various aspects of translational regulation can be found elsewhere (de Moor et al. 2005; Piccioni et al. 2005; Wilhelm and Smibert 2005; Hentze et al. 2007; Jackson and Standart 2007; Thompson et al. 2007) .
The majority of known translation regulatory proteins target the initiation step. Initiation in eukaryotes is a very elaborated process that requires the action of about 30 polypeptides in addition to the ribosomal proteins (Jackson 2005; Pestova et al. 2007 ). Initiation can be divided into three substeps: (1) recruitment of the small (40S) ribosomal subunit to the 59 end of the mRNA, (2) scanning along the 59 UTR and initiator AUG recognition, and (3) large (60S) ribosomal subunit joining. Examples of regulation at each of these steps are discussed below.
CAP-DEPENDENT MECHANISMS
During their synthesis in the nucleus, mRNAs are endowed with a m 7 GpppN (m 7 G) cap structure at their 59 end. In addition to promoting splicing, nuclear export, and stability, the cap is required for translation of nearly all mRNAs. Some transcripts, however, can initiate translation in a capindependent fashion making use of RNA structures called internal ribosome entry sites (IRESs) (Stoneley and Willis 2004; Jackson 2005) . The cap is recognized by the capbinding complex eIF4F, composed of the eukaryotic translation initiation factors (eIFs) eIF4E, eIF4G, and eIF4A ( Fig. 1) . eIF4E directly binds to the cap, while eIF4G serves as a scaffolding protein that binds to the other components of the complex and, at least in higher eukaryotes, to eIF3. Because eIF3, in turn, binds to the small ribosomal subunit, these set of interactions are thought to bridge the 43S complex (an assembly of the small ribosomal subunit with eIF3 and other initiation factors) to the mRNA (Fig. 1) . eIF4G also binds to poly(A) binding protein (PABP), promoting the formation of a cap-eIF4E-eIF4G-PABP-poly(A) complex that results in mRNA pseudo-circularization and is thought to underline the translational synergy between the cap and the poly(A) tail (for review, see Kahvejian et al. 2001) . The formation of an mRNA ''closed loop'' provides a physical framework for the action of 39 UTR binding proteins on translation initiation at the 59 end. Indeed, such a closed loop seems to be required for the function of some inhibitory complexes that bind to the 39 UTR, including micro-ribonucleoprotein particles (miRNPs) (Mazumder et al. 2001; Humphreys et al. 2005; Wang et al. 2006; Wakiyama et al. 2007) .
Given the relevance of the cap structure in translation initiation, it is not surprising that a large number of translation regulatory mechanisms target the cap or its associated factors. A variety of strategies are used to interfere with cap function, including blocking the access of eIF4E to the cap, preventing the eIF4E-eIF4G interaction, interfering with the eIF4G-eIF3 interaction, and sterically hindering ribosome recruitment (Fig. 1) .
A regulator that blocks the access of the eIF4E to the cap is Drosophila 4EHP (4E homologous protein). 4EHP binds to the cap but cannot interact with eIF4G because it lacks the corresponding interaction site and, thus, acts as a decoy eIF4E (Fig. 1 ). Alone, 4EHP shows a low affinity for the cap structure and does not repress translation (Zuberek et al. 2007 ). However, in conjunction with the 39 UTR binding protein Bicoid, 4EHP inhibits the translation of caudal mRNA at the anterior pole of early Drosophila embryos (Cho et al. 2005) . 4EHP is also necessary for the optimal translational repression of maternal hunchback mRNA at the posterior pole. In this case, the complex Pumilio/ Nanos/Brain tumor (Pum/Nos/Brat) binds to the 39 UTR of hunchback, recruiting 4EHP via interactions with Brat (Cho et al. 2006) . These translational repression events create opposing gradients of Caudal and Hunchback that are critical to activate axis-specific patterns of gene expression. In the case of hunchback mRNA, an additional mechanism contributes to translational silencing through mRNA deadenylation mediated by Nos (Wreden et al. 1997) . Nos and Pum can interact with different subunits of the deadenylase CCR4/NOT, although it is not known whether this deadenylase functions in hunchback repression (Goldstrohm et al. 2006; Kadyrova et al. 2007 ). The use of multiple mechanisms to ensure appropriate translational regulation of a given mRNA is a recurrent feature in development and highlights the complexity of translation regulatory modes (see below).
Interference with the access of eIF4E to the cap has also been proposed as a mechanism for miRNP-mediated repression. The miRNP component Ago2 contains a capbinding motif that is required for translational repression when Ago2 is artificially tethered to the 39 UTR (Kiriakidou et al. 2007) . Recently developed in vitro assays are consistent with miRNPs inhibiting translation initiation in a capand poly(A)-dependent fashion. However, the true mechanism of translational repression by miRNPs remains controversial, as some studies performed in vivo support a role of miRNPs in repression of post-initiation steps. These controversies have been extensively reviewed in two recent reports and will not be further discussed here Standart and Jackson 2007 , and references therein).
Another strategy to inhibit cap-dependent translation is to block the eIF4E-eIF4G interaction. This approach is used by the so-called 4E-binding proteins (4E-BPs), which bind to eIF4E in the same region that is recognized by eIF4G, preventing the formation of the cap-binding complex. General 4E-BPs, such as 4E-BP1, bind to eIF4E depending on their phosphorylation state and play a pivotal role in the global control of mRNA translation under mitogenic stimulation or stress conditions (Dann and Thomas 2006) . Message-specific 4E-BPs have also been described, which, as for 4EHP, are recruited to specific transcripts via 39 UTR binding proteins. The proteins Cup and Maskin are examples of this type of 4E-BPs (Fig. 1) .
Cup represses the translation of oskar and nanos mRNAs, two transcripts that are transported to and localized at the posterior pole of Drosophila oocytes and embryos and that must be silenced prior to their localization (Wilhelm et al. 2003; Nakamura et al. 2004; Nelson et al. 2004; Zappavigna et al. 2004) . Cup is recruited to oskar and nanos mRNAs by the 39 UTR binding proteins Bruno and Smaug, respectively. As for hunchback, additional mechanisms contribute to translational repression of these transcripts, including Bruno-driven mRNA oligomerization and Smaug-dependent deadenylation (Chekulaeva et al. 2006; Jeske et al. 2006; Zaessinger et al. 2006) . The examples of hunchback and nanos mRNAs illustrate that deadenylation often cooperates with mechanisms of translational control FIGURE 1. Translation initiation and its regulation by RNA-binding proteins. The translation initiation pathway and factors are depicted in gray (see text for details). The term eIF has been omitted for simplicity. Only the translation factors mentioned in this review are shown. The regulators and the steps that they inhibit are shown in red. Cap-dependent mechanisms of translational control target the association of eIF4E with the cap structure (yellow oval), the interaction of eIF4E with eIF4G, the interaction of eIF4G with eIF3, or sterically hinder 43S ribosomal recruitment. Cap-independent mechanisms can block 43S recruitment, ribosomal scanning, or 60S subunit joining.
involving direct interference with initiation factors. The regulation of cyclin B1 mRNA also follows these principles. The 4E-BP protein Maskin represses the translation of cyclin B1 mRNA during late Xenopus oogenesis and is recruited to this transcript by CPEB (cytoplasmic polyadenylation element binding protein), a major regulator of mRNA polyadenylation and translation in vertebrates (Richter 2007) . In addition to Maskin, CPEB recruits the deadenylase PARN, which contributes to mRNA silencing by keeping the poly(A) tail short ( Fig. 2A ; Kim and Richter 2006) . Intriguingly, a protein complex containing CPEB, the repressor helicase p54, the vertebrate Cup homolog 4E-T (4E-transporter), and the eIF4E family member 4E1b, among other proteins, has been detected in early Xenopus oocytes (Minshall et al. 2007 ). As described for 4EHP, 4E1b
shows low affinity for the cap structure and for eIF4G, suggesting that mechanisms combining specific 4E-BPs with decoy isoforms of eIF4E may operate for translational repression.
The interaction of eIF4G with eIF3 can also be a target of regulation. Ceruloplasmin mRNA translation is repressed during inflammation by the binding of the GAIT (IFN-g activated inhibitor of translation) complex to its 39 UTR. GAIT is composed of four proteins: GAPDH, NSAP1, GluProRS, and the large ribosomal subunit protein L13a (Sampath et al. 2004) . Translational repression seems to require the formation of a transcript closed loop in order to place the GAIT complex in proximity to the 59 end (Mazumder et al. 2001) . L13a then binds to eIF4G, impeding its interaction with eIF3 and blocking 43S complex recruitment (Kapasi et al. 2007 ).
The iron regulatory proteins (IRPs) use an alternative mechanism to prevent 43S recruitment without affecting the association of the eIF4F complex with the mRNA. Under conditions of low iron, IRP binds to a cap-proximal stem-loop in the 59 UTR of ferritin mRNA and sterically hinders 43S recruitment (Muckenthaler et al. 1998) . The finding that RNA-binding proteins with no role in translation can become repressors when bound to structures located within z40 nucleotides of the cap supports a steric mode of inhibition (Stripecke et al. 1994 ).
CAP-INDEPENDENT MECHANISMS
Cap-independent mechanisms of translational control are those that occur efficiently in the absence of the m 7 G cap structure. In this section, we will describe mechanisms that target translation initiation steps after eIF4F formation. We will not discuss regulation of IRES-dependent translation by UTR-binding proteins, as this type of translational control is mechanistically poorly understood.
Translational repression of msl-2 mRNA by Sex-lethal (SXL) is an essential regulatory step of X-chromosome dosage compensation in Drosophila. SXL binds to both the 59 and 39 UTRs of msl-2 and inhibits translation by a double-block mechanism: 39-bound SXL inhibits the recruitment of the 43S ribosomal complex while 59-bound SXL blocks the scanning of those complexes that presumably have escaped the 39 UTR-mediated control ( Fig. 1 ; Beckmann et al. 2005) . Translational repression requires that SXL recruits the protein UNR to the 39 UTR of msl-2 Duncan et al. 2006) and is equally efficient when the canonical m 7 GpppN cap at the 59 end of the mRNA is substituted by an ApppN cap, which does not support eIF4E binding (Gebauer et al. 2003) . How inhibition of 43S recruitment and scanning occurs is an open question, but the fact that a m 7 G cap is not essential suggests that eIF4E is not a target.
LOX (15-lipoxygenase) mRNA translation is repressed in erythroid precursor cells by the binding of hnRNPs K and E1 to its 39 UTR. Sucrose gradient and toe-print analysis showed that hnRNP K/E1 inhibit the joining of the 60S ribosomal subunit to the 40S subunit placed at the initiation codon ( Fig. 1 ; Ostareck et al. 2001) . Repression occurs efficiently when translation is driven by the EMCV (encephalomyocarditis virus) or CSFV (classical swine fever virus) IRESs, indicating that LOX mRNA is repressed in a cap-independent fashion (Ostareck et al. 2001) . The specific factors targeted for inhibition are unknown.
REVERSIBLE TRANSLATIONAL REPRESSION
Translational regulation is often regarded as a rapid and ''reversible'' way to control gene expression. However, although reversibility is an essential component of many translational regulatory mechanisms, not all mechanisms are reversible. For example, msl-2 translational repression is thought to persist throughout life in every tissue of female flies.
Relatively little is known about mechanisms that reverse translational repression. In most available examples, relief from translation inhibition is achieved by remodeling of the repressed RNP or, more often, by removal of the repressor from the target mRNA (Fig. 2) . Strategies for removal include phosphorylation of the repressor and binding of the regulator to small molecules or to activator factors.
One of the best examples of de-repression by RNP remodeling is that of Xenopus cyclin B1 mRNA. As mentioned above, translation of this transcript is repressed by a complex nucleated by CPEB on the 39 UTR that contains Maskin and PARN. Two phosphorylation events are thought to be responsible for the full translational activation of cyclin B1 during oocyte maturation. On one hand, phosphorylation of CPEB by Aurora A causes the dissociation of PARN, allowing productive polyadenylation by a cytoplasmic complex composed of the scaffolding protein symplekin, CPSF (cleavage and polyadenylation specificity factor), and the cytoplasmic poly(A) polymerase Gld2 ( Fig.  2A ; Barnard et al. 2004; Kim and Richter 2006) . Basal levels of this complex can be found associated to CPEB in immature oocytes, but association increases upon maturation (Mendez et al. 2000; Barnard et al. 2004) . Importantly, CPEB is a necessary factor for polyadenylation (Hake and Richter 1994) . Elongation of the poly(A) tail then allows recruitment of PABP, which binds to eIF4G and displaces Maskin from eIF4E . On the other hand, phosphorylation of Maskin by cdk1 contributes to its dissociation from eIF4E (Barnard et al. 2005) . Cycles of phosphorylation and dephosphorylation of Maskin by cdk1 and calcineurin, respectively, combined with phosphorylation and dephosphorylation of CPEB direct the cyclic production of cyclin B1 in extracts that mimic the mitotic cell cycles of the early Xenopus embryo (Groisman et al. 2002; Cao et al. 2006) . Thus, CPEB is an example of a regulator that can behave as a repressor or an activator depending on its phosphorylation status, revealing yet another level of complexity in translational regulation.
Phosphorylation also plays an important role in other forms of de-repression. In order to prevent LOX mRNA translation, hnRNP K binds to the 39 UTR-located differentiation control element (DICE) through its KH domain 3. A tyrosine residue within this domain (Y458) is critical for DICE binding (Messias et al. 2006) . Phosphorylation of Y458 by c-Src impairs DICE binding and translation inhibition in vitro and in Hela cells ( Fig. 2B ; OstareckLederer et al. 2002; Messias et al. 2006) . Activation of c-Src is mediated by direct binding to hnRNP K (Adolph et al. 2007 ). Thus, hnRNP K is both an activator and a substrate of c-Src in these systems. Interestingly, arginine dimethylation of hnRNP K by PRMT1 prevents its interaction with c-Src, suggesting that this modification could be critical to regulate the timing of LOX mRNA de-repression (OstareckLederer et al. 2006) . Deciphering whether this mechanism operates during red blood cell differentiation, in addition to Hela cells and reticulocyte lysates, awaits the establishment of the appropriate experimental system.
The regulator IRP leads a double life. Under conditions of low iron, it behaves as a RNA-binding protein that recognizes specific stem-loops called iron responsive elements (IREs) in the 59 or 39 UTRs of mRNAs encoding factors involved in iron homeostasis (Wallander et al. 2006 ). As explained above, binding of IRP to the 59 IRE of ferritin mRNA represses translation. Under conditions of high iron, IRP binds to a cubic [4Fe-4S] cluster and shows cytoplasmic aconitase activity (Fig. 2C) . The two functions of IRP, translational repression and aconitase, are mutually exclusive. Cysteine 437 of IRP is particularly critical for RNA binding and is essential to anchor the iron-sulphur cluster (Hirling et al. 1994) . Consistently, binding of IRP to the [4Fe-4S] cluster results in the loss of affinity for RNA and the subsequent translation of ferritin mRNA (Hirling et al. 1994) .
Reversible translational repression is a common theme in mRNA localization. In order to achieve localized expression, the mRNA is silenced after transcription and is only expressed when it reaches its final cellular destiny. A mechanism for local translational activation has been recently proposed (Zaessinger et al. 2006) . Localized expression of Nos is accomplished by the translational repression of the z96% nanos mRNA present in the bulk cytoplasm of the early Drosophila embryo versus the translational activation of the z4% of posteriorly localized nanos mRNA. Translational repression is carried out by Smaug, which binds to the 39 UTR of nanos and recruits both the 4E-BP protein Cup and the deadenylase CCR4/NOT (see above). At the posterior pole, translation de-repression requires the posteriorly localized factor Oskar. This protein has been shown to interact with the RNA-binding domain of Smaug in yeast two-hybrid and GST pull-down assays (Dahanukar et al. 1999 ). In addition, overexpression of Oskar prevents nanos deadenylation and decreases the interaction of nanos with Smaug (Zaessinger et al. 2006 ). The simplest explanation for these results is that nanos translational derepression is achieved by Oskar directly inhibiting Smaug binding. Further experiments will be required to test whether this mechanism indeed operates in vivo.
CONCLUDING REMARKS
Recent progress on translational control highlights the complexity and versatility of regulation by RNA-binding proteins. Multistep overlapping mechanisms are often used to keep the mRNA silenced. In addition, a single regulator can exploit different modes of control, sometimes with opposing outcomes, which depend on the binding context and the composition of the ribonucleoprotein particle at the time of binding. Microarray analyses have revealed that regulators bind to multiple mRNAs, usually covering >10% of the transcriptome, leading to networks of post-transcriptional regulation that often include factors involved in the same biological pathway and that constitute genuine post-transcriptional operons (Keene 2007) . New small RNA molecules have been uncovered that regulate both the translation and stability of the mRNA. Despite these discoveries, much remains to be learned. Mechanistic understanding on how regulators can affect ribosomal scanning, subunit joining, elongation, or termination is lacking. Except for a few examples, how translational repression is reversed and which are the signaling cascades that connect mRNA-specific translational control with general cellular function are unknown. Ultimately, research on these aspects will help us understand not only how the translation process itself occurs, but also how it is altered in disease.
